Related Experiment Video
Updated: Aug 12, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Hypertension in pregnancy
1Department of Obstetrics and Gynecology, University of Chicago, Ill.
Insights
Hypertension in pregnancy, particularly preeclampsia-eclampsia, poses significant risks. Recent guidelines recommend specific blood pressure thresholds for treatment and favored medications like hydralazine and methyldopa.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Perinatology
Background:
- Pregnancy hypertension complicates 10% of pregnancies, causing maternal and fetal morbidity/mortality.
- Diagnostic challenges and conflicting management strategies exist for hypertensive disorders in gestation.
- Preeclampsia-eclampsia represents the most severe form of pregnancy-induced hypertension.
Observation:
- The National High Blood Pressure Education Program's Consensus Report offers updated management recommendations.
- Key recommendations include adopting the 1972 ACOG classification and using the fifth Korotkoff sound for diastolic pressure.
- Treatment initiation is advised for diastolic pressures ≥105 mm Hg or ≥100 mm Hg in chronic hypertension near term.
Findings:
- Parenteral hydralazine and methyldopa are recommended for acute hypertensive crises and chronic hypertension, respectively.
- Magnesium sulfate remains the standard for eclampsia prevention/treatment, with a call for further efficacy trials.
- Diuretics are generally contraindicated in preeclampsia but may be continued if pre-conception use or in salt-sensitive chronic hypertension.
Implications:
- These guidelines aim to standardize and improve the management of hypertensive disorders during pregnancy.
- Evidence-based recommendations can reduce maternal and fetal complications associated with pregnancy hypertension.
- Further research, particularly on magnesium sulfate's role, is crucial for refining treatment protocols.
Abstract:
High blood pressure, which complicates approximately 10% of all pregnancies, remains a major cause of morbidity and mortality for both mother and fetus. A relative paucity of investigative data, as well as the frequent difficulty in making an etiological diagnosis by clinical criteria alone, may be among the reasons why there are many conflicts about the management of hypertension during pregnancy. This clinical conference summarizes current concepts regarding the hypertensive disorders of gestation, focusing on the most dangerous cause, preeclampsia-eclampsia. It further highlights a recent report of the Working Group on High Blood Pressure in Pregnancy convened by the National High Blood Pressure Education Program at the National Heart, Lung, and Blood Institute (the Consensus Report). Among the Working Group's most interesting recommendations in controversial areas were a return to the classification schema suggested by the American College of Obstetricians and Gynecologists in 1972, use of the fifth Korotkoff sound to determine diastolic blood pressure levels, and institution of treatment with antihypertensive drugs for sudden elevations of blood pressure near term to diastolic levels greater than or equal to 105 mm Hg or for levels of 100 mm Hg or higher in pregnant women with chronic hypertension. The Consensus Report further recommended parenteral hydralazine and methyldopa as the drugs of choice for the acute hypertensive crisis and management of chronic hypertension, respectively, based on the long histories of safe use of these agents in gravidas. Parenteral magnesium sulfate remained the preferred therapeutic approach for avoiding or treating the convulsive complication, eclampsia, but the Working Group underscored the need for controlled trials of magnesium's efficacy. Finally, they noted that diuretics should be avoided in preeclampsia, but that these drugs can be continued during gestation if taken before conception, and may be prescribed to pregnant women with chronic hypertension who appear overly salt sensitive.
Related Concept Videos
Hormonal Regulation
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management

